chr13:32913457:C>G Detail (hg19) (BRCA2)

Information

Genome

Assembly Position
hg19 chr13:32,913,457-32,913,457
hg38 chr13:32,339,320-32,339,320 View the variant detail on this assembly version.

HGVS

Type Transcript Protein
RefSeq NM_000059.3:c.4965C>G NP_000050.2:p.Tyr1655Ter
Ensemble ENST00000530893.7:c.4596C>G ENST00000530893.7:p.Tyr1532Ter
ENST00000544455.6:c.4965C>G ENST00000544455.6:p.Tyr1655Ter
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

Frequency

JP HGVD:[No Data.]
ToMMo:[No Data.]
NCBN:[No Data.]
NCBN(Hondo):[No Data.]
NCBN(Ryukyu):[No Data.]
East asia ExAC:<0.001

Prediction

ClinVar

Clinical Significance Pathogenic
Review star
Show details
Links
Type Database ID Link
Gene MIM 600185 OMIM
HGNC 1101 HGNC
Ensembl ENSG00000139618 Ensembl
NCBI NCBI
Gene Cards Gene Cards
OncoKB OncoKB
Type Database ID Link
Variant TogoVar
COSMIC
MONDO
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
Clinical significance Last evaluated Review status Condition Origin Links
Pathogenic 2016-09-08 reviewed by expert panel Breast-ovarian cancer, familial, susceptibility to, 2 germline unknown Detail
Pathogenic 2022-11-02 criteria provided, multiple submitters, no conflicts not provided germline unknown Detail
Pathogenic 2023-05-24 criteria provided, multiple submitters, no conflicts Hereditary cancer-predisposing syndrome germline Detail
Pathogenic 2015-02-02 no assertion criteria provided Fanconi anemia complementation group D1,Breast-ovarian cancer, familial, susceptibility to, 2 germline Detail
Pathogenic 2015-02-02 no assertion criteria provided Fanconi anemia complementation group D1,Breast-ovarian cancer, familial, susceptibility to, 2 germline Detail
Pathogenic 2024-01-21 criteria provided, multiple submitters, no conflicts hereditary breast ovarian cancer syndrome germline Detail
Pathogenic 2017-04-20 criteria provided, single submitter not specified germline Detail
Pathogenic 2022-02-04 criteria provided, single submitter Fanconi anemia complementation group D1,Malignant tumor of prostate,Breast-ovarian cancer, familial, susceptibility to, 2,Glioma susceptibility 3,Familial cancer of breast,medulloblastoma,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2 unknown Detail
Pathogenic 2022-02-04 criteria provided, single submitter Fanconi anemia complementation group D1,Malignant tumor of prostate,Breast-ovarian cancer, familial, susceptibility to, 2,Glioma susceptibility 3,Familial cancer of breast,medulloblastoma,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2 unknown Detail
Pathogenic 2022-02-04 criteria provided, single submitter Fanconi anemia complementation group D1,Malignant tumor of prostate,Breast-ovarian cancer, familial, susceptibility to, 2,Glioma susceptibility 3,Familial cancer of breast,medulloblastoma,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2 unknown Detail
Pathogenic 2022-02-04 criteria provided, single submitter Fanconi anemia complementation group D1,Malignant tumor of prostate,Breast-ovarian cancer, familial, susceptibility to, 2,Glioma susceptibility 3,Familial cancer of breast,medulloblastoma,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2 unknown Detail
Pathogenic 2022-02-04 criteria provided, single submitter Fanconi anemia complementation group D1,Malignant tumor of prostate,Breast-ovarian cancer, familial, susceptibility to, 2,Glioma susceptibility 3,Familial cancer of breast,medulloblastoma,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2 unknown Detail
Pathogenic 2022-02-04 criteria provided, single submitter Fanconi anemia complementation group D1,Malignant tumor of prostate,Breast-ovarian cancer, familial, susceptibility to, 2,Glioma susceptibility 3,Familial cancer of breast,medulloblastoma,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2 unknown Detail
Pathogenic 2022-02-04 criteria provided, single submitter Fanconi anemia complementation group D1,Malignant tumor of prostate,Breast-ovarian cancer, familial, susceptibility to, 2,Glioma susceptibility 3,Familial cancer of breast,medulloblastoma,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2 unknown Detail
Pathogenic 2022-02-04 criteria provided, single submitter Fanconi anemia complementation group D1,Malignant tumor of prostate,Breast-ovarian cancer, familial, susceptibility to, 2,Glioma susceptibility 3,Familial cancer of breast,medulloblastoma,Wilms tumor 1,Pancreatic cancer, susceptibility to, 2 unknown Detail
Pathogenic 2018-12-01 no assertion criteria provided Neoplasm of ovary germline Detail
Pathogenic 2020-11-11 criteria provided, single submitter Fanconi anemia complementation group D1 paternal Detail
Pathogenic no assertion criteria provided unknown Detail
Pathogenic 2023-09-29 criteria provided, single submitter Familial cancer of breast unknown Detail
CIViC
[No Data.]
DisGeNET
Score Disease name Description Source Pubmed Links
0.240 Breast-ovarian cancer, familial, susceptibility to, 2 NA CLINVAR Detail
0.174 Breast Cancer, Familial NA CLINVAR Detail
0.391 Hereditary Breast and Ovarian Cancer Syndrome NA CLINVAR Detail
0.128 Neoplastic Syndromes, Hereditary NA CLINVAR Detail
0.560 FANCONI ANEMIA, COMPLEMENTATION GROUP D1 NA CLINVAR Detail
0.001 Epithelial ovarian cancer Three ovarian cancer cell lines (PEO1, PEO4, and PEO6) were derived from a BRCA2... BeFree 19654294 Detail
0.002 Malignant neoplasm of ovary Three ovarian cancer cell lines (PEO1, PEO4, and PEO6) were derived from a BRCA2... BeFree 19654294 Detail
0.002 ovarian carcinoma Three ovarian cancer cell lines (PEO1, PEO4, and PEO6) were derived from a BRCA2... BeFree 19654294 Detail
Annotation

Annotations

DescrptionSourceLinks
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND Breast-ovarian cancer, familial, susceptibility to, ... ClinVar Detail
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND not provided ClinVar Detail
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND Hereditary cancer-predisposing syndrome ClinVar Detail
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND multiple conditions ClinVar Detail
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND multiple conditions ClinVar Detail
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND Hereditary breast ovarian cancer syndrome ClinVar Detail
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND not specified ClinVar Detail
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND multiple conditions ClinVar Detail
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND multiple conditions ClinVar Detail
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND multiple conditions ClinVar Detail
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND multiple conditions ClinVar Detail
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND multiple conditions ClinVar Detail
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND multiple conditions ClinVar Detail
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND multiple conditions ClinVar Detail
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND multiple conditions ClinVar Detail
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND Neoplasm of ovary ClinVar Detail
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND Fanconi anemia complementation group D1 ClinVar Detail
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND Malignant tumor of breast ClinVar Detail
NM_000059.4(BRCA2):c.4965C>G (p.Tyr1655Ter) AND Familial cancer of breast ClinVar Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Three ovarian cancer cell lines (PEO1, PEO4, and PEO6) were derived from a BRCA2 mutation [5193C&gt;... DisGeNET Detail
Three ovarian cancer cell lines (PEO1, PEO4, and PEO6) were derived from a BRCA2 mutation [5193C&gt;... DisGeNET Detail
Three ovarian cancer cell lines (PEO1, PEO4, and PEO6) were derived from a BRCA2 mutation [5193C&gt;... DisGeNET Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
dbSNP
rs80358721 dbSNP
Genome
hg19
Position
chr13:32,913,457-32,913,457
Variant Type
snv
Reference Allele
C
Alternative Allele
G
East Asian Chromosome Counts (ExAC)
8614
East Asian Allele Counts (ExAC)
0
East Asian Heterozygous Counts (ExAC)
0
East Asian Homozygous Counts (ExAC)
0
East Asian Allele Frequency (ExAC)
0.0
Chromosome Counts in All Race (ExAC)
118848
Allele Counts in All Race (ExAC)
1
Heterozygous Counts in All Race (ExAC)
1
Homozygous Counts in All Race (ExAC)
0
Allele Frequency in All Race (ExAC)
8.414108777598277E-6
Genome browser